Procyon Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Procyon Advisors’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-11,808	Closed	-$371K	–	602
2026 Q2	$371K	Buy	+11,808	New	+$348K	0.02%	412

Other funds holding CPRX

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Procyon Advisors's CPRX Position: Q3 2026 in Review

Procyon Advisors sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 11,808 shares — an estimated $371K sold.

Procyon Advisors first reported a position in CPRX in Q2 2026 and held it in 1 quarter. The position peaked at $371K in Q2 2026. 1 fund tracked by Wall St. Rank holds CPRX as of Q3 2026.

Procyon Advisors reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
Procyon Advisors sold 11,808 Catalyst Pharmaceutical shares in Q3 2026, an estimated $371K.
Procyon Advisors first reported a position in Catalyst Pharmaceutical in Q2 2026 and held it in 1 quarter.
Procyon Advisors's Catalyst Pharmaceutical position peaked at $371K in Q2 2026.
1 fund tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on Procyon Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.